OCTAVE SPECIALTY GROUP INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that OCTAVE SPECIALTY GROUP INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $251.22M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $235.82M | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | $124.73M | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | $53.61M | Mar 6, 2025 |
| FY2020 | Dec 31, 2020 | $156.00M | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | $496.00M | Mar 1, 2021 |
| FY2020 | Dec 31, 2018 | $511.00M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $622.00M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $506.77M | Feb 28, 2019 |
| FY2012 | Dec 31, 2012 | $685.69M | Mar 22, 2013 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $143.38M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $92.02M | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | $51.28M | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | $30.70M | Mar 6, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($259.09M) | Mar 4, 2026 |
| FY2024 | Dec 31, 2024 | ($548.27M) | Mar 6, 2025 |
| FY2024 | Sep 30, 2024 | ($27.50M) | Mar 6, 2025 |
| FY2024 | Jun 30, 2024 | ($750.0K) | Mar 6, 2025 |
| FY2024 | Mar 31, 2024 | $20.07M | Mar 6, 2025 |
| FY2024 | Dec 31, 2023 | ($15.69M) | Mar 6, 2025 |
| FY2024 | Sep 30, 2023 | $65.87M | Mar 6, 2025 |
| FY2024 | Jun 30, 2023 | ($13.13M) | Mar 6, 2025 |
| FY2024 | Mar 31, 2023 | ($33.42M) | Mar 6, 2025 |
| FY2024 | Dec 31, 2022 | $522.12M | Mar 6, 2025 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | ($175.00M) | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | ($311.00M) | Mar 1, 2021 |
| FY2020 | Dec 31, 2018 | ($1.54B) | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | ($221.00M) | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $830.31M | Feb 28, 2019 |
| FY2012 | Dec 31, 2012 | ($613.90M) | Mar 22, 2013 |
| FY2012 | Dec 31, 2011 | $3.56M | Mar 22, 2013 |
| FY2011 | Dec 31, 2010 | ($2.09B) | Mar 22, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.22B | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $8.06B | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | $8.43B | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | $7.97B | Mar 6, 2025 |
| FY2020 | Dec 31, 2020 | $13.22B | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | $13.32B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $14.59B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $23.19B | Feb 28, 2019 |
| FY2015 | Apr 30, 2013 | $28.85B | May 11, 2016 |
| FY2012 | Dec 31, 2012 | $27.01B | Mar 22, 2013 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.14B | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $6.86B | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | $7.00B | Mar 6, 2025 |
| FY2020 | Dec 31, 2020 | $12.07B | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | $11.78B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $12.96B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $21.55B | Feb 28, 2019 |
| FY2015 | Apr 30, 2013 | $28.39B | May 11, 2016 |
| FY2012 | Dec 31, 2012 | $30.25B | Mar 22, 2013 |
| FY2012 | Dec 31, 2011 | $30.26B | Mar 22, 2013 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $715.79M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $798.36M | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | $1.36B | Mar 6, 2025 |
| FY2020 | Dec 31, 2020 | $1.08B | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | $1.48B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $1.59B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $1.38B | Feb 28, 2019 |
| FY2012 | Dec 31, 2012 | ($3.91B) | Mar 22, 2013 |
| FY2012 | Dec 31, 2011 | ($3.81B) | Mar 22, 2013 |
| FY2011 | Dec 31, 2010 | ($2.01B) | Mar 22, 2012 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $540.35M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $418.23M | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | $69.69M | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | $46.05M | Mar 6, 2025 |
| FY2015 | Apr 30, 2013 | $514.51M | May 11, 2016 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $370.43M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $683.64M | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | $1.25B | Mar 6, 2025 |
| FY2020 | Dec 31, 2020 | $759.00M | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | $1.20B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $1.42B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $1.23B | Feb 28, 2019 |
| FY2012 | Dec 31, 2012 | ($6.30B) | Mar 22, 2013 |
| FY2012 | Dec 31, 2011 | ($6.04B) | Mar 22, 2013 |
| FY2011 | Dec 31, 2010 | ($4.04B) | Mar 22, 2012 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $29.61M | Mar 6, 2025 |
| FY2024 | Dec 31, 2023 | $7.34M | Mar 6, 2025 |
| FY2024 | Dec 31, 2022 | $6.33M | Mar 6, 2025 |
| FY2020 | Dec 31, 2020 | $20.00M | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | $24.00M | Mar 1, 2021 |
| FY2020 | Dec 31, 2018 | $63.00M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $624.00M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $91.03M | Feb 28, 2019 |
| FY2012 | Dec 31, 2012 | $43.84M | Mar 22, 2013 |
| FY2012 | Dec 31, 2011 | $16.00M | Mar 22, 2013 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $117.56M | Mar 4, 2026 |
| FY2025 | Oct 31, 2025 | $100.00M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $0 | Mar 4, 2026 |
| FY2020 | Dec 31, 2020 | $2.74B | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | $2.82B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $2.93B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $991.70M | Feb 28, 2019 |
| FY2013 | Dec 31, 2013 | $963.18M | Mar 3, 2014 |
| FY2013 | Dec 31, 2012 | $150.17M | Mar 3, 2014 |
| FY2012 | Dec 31, 2011 | $223.60M | Mar 22, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (5) | Mar 4, 2026 |
| FY2024 | Dec 31, 2024 | (10) | Mar 6, 2025 |
| FY2024 | Sep 30, 2024 | 0 | Mar 6, 2025 |
| FY2024 | Jun 30, 2024 | 0 | Mar 6, 2025 |
| FY2024 | Mar 31, 2024 | 0 | Mar 6, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Mar 6, 2025 |
| FY2024 | Sep 30, 2023 | 1 | Mar 6, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Mar 6, 2025 |
| FY2024 | Mar 31, 2023 | 0 | Mar 6, 2025 |
| FY2024 | Dec 31, 2022 | 11 | Mar 6, 2025 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (5) | Mar 4, 2026 |
| FY2024 | Dec 31, 2024 | (10) | Mar 6, 2025 |
| FY2024 | Sep 30, 2024 | 0 | Mar 6, 2025 |
| FY2024 | Jun 30, 2024 | 0 | Mar 6, 2025 |
| FY2024 | Mar 31, 2024 | 0 | Mar 6, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Mar 6, 2025 |
| FY2024 | Sep 30, 2023 | 1 | Mar 6, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Mar 6, 2025 |
| FY2024 | Mar 31, 2023 | 0 | Mar 6, 2025 |
| FY2024 | Dec 31, 2022 | 11 | Mar 6, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 45.01M | Mar 4, 2026 |
| FY2024 | Dec 31, 2024 | 46.51M | Mar 6, 2025 |
| FY2020 | Dec 31, 2020 | 45.81M | Mar 1, 2021 |
| FY2019 | Dec 31, 2019 | 45.56M | Mar 2, 2020 |
| FY2019 | Dec 31, 2018 | 45.34M | Mar 2, 2020 |
| FY2014 | Dec 31, 2014 | 45.01M | Mar 2, 2015 |
| FY2014 | Dec 31, 2013 | 45.00M | Mar 2, 2015 |
| FY2012 | Dec 31, 2012 | 308.02M | Mar 22, 2013 |
| FY2012 | Dec 31, 2011 | 308.02M | Mar 22, 2013 |
| FY2011 | Dec 31, 2010 | 308.02M | Mar 22, 2012 |